PatternsRadar
Sign in

LOTUSEYELotus Eye Hospital and Institute Limited

NSE
Full chart
115.37INR-0.24 (-0.21%)Close · 6 Oct 2026
10 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹240 CrMarket cap
1607.0P/E (TTM)
87.4%Delivery

Filings & corporate actions

73 results filed
CSV
Next results · Q2 FY27
Expected 12 Nov 2026 – 15 Nov 2026
Estimate: filed 43–46 days after quarter end, last 5 times
Dividend
₹0.50 per share · last 18 Sept 2023
2026
  • 10 AugresultsResults · Q1 FY27 · standalone+3.6%NSE
  • 16 JulshareholdingShareholding · 30 Jun 2026+2.0%NSE
  • 26 MayresultsResults · Q4 FY26 · standalone-1.0%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+2.1%NSE
  • 11 FebresultsResults · Q3 FY26 · standalone-3.2%NSE
  • 9 JanshareholdingShareholding · 31 Dec 2025-3.4%NSE

Reaction to results · all yearsrose on day 0 in 26 of 73 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2710 Aug 2026+3.6%+0.4%-4.3%1.5×
Q4 FY2626 May 2026-1.0%-0.1%+14.3%0.5×
Q3 FY2611 Feb 2026-3.2%+0.7%-15.7%0.2×
Q2 FY2612 Nov 2025-2.4%-10.5%+0.5%0.9×
Q1 FY2612 Aug 2025+2.7%+21.9%+63.8%3.8×
Q4 FY2529 May 2025-0.2%-1.5%-1.0%0.5×
Q3 FY2512 Feb 2025-4.0%-0.3%-8.9%2.2×
Q2 FY2512 Nov 2024-1.6%+2.5%+10.8%0.8×
Q1 FY2512 Aug 2024+13.0%+14.8%+11.1%13.2×
Q4 FY2427 May 2024-1.4%-12.6%-2.1%1.0×
Q3 FY2415 Feb 2024+2.0%+0.7%-16.6%0.2×
Q2 FY2415 Nov 2023+9.6%+2.5%-8.0%11.8×
Q1 FY2414 Aug 2023-5.0%-12.9%-6.9%0.5×
Q4 FY2325 May 2023-3.7%-2.5%+11.8%0.6×
Q3 FY2315 Feb 2023+1.6%+2.1%-11.3%0.3×
Q2 FY2315 Nov 2022-3.8%+22.2%+5.9%2.0×
Q1 FY2310 Aug 2022-0.6%-11.0%-8.7%0.4×
Q4 FY2226 May 2022-2.2%-0.9%+0.9%2.0×
Q3 FY2215 Feb 2022+1.6%+2.8%+5.1%0.1×
Q2 FY2214 Nov 2021+2.6%+3.0%+15.1%1.0×
Q1 FY2215 Aug 2021+1.8%-0.8%+6.6%0.7×
Q4 FY211 Jul 2021-2.8%-6.3%-14.5%0.2×
Q3 FY2110 Feb 2021-0.6%+1.4%+11.0%0.6×
Q2 FY2112 Nov 2020-0.7%+6.3%+4.4%3.2×
Q1 FY2118 Sept 2020-2.1%-2.8%-0.3%0.1×
Q4 FY2031 Jul 2020-5.1%+4.9%+17.4%0.5×
Q3 FY207 Feb 2020-3.5%-6.8%-6.1%0.5×
Q2 FY2014 Nov 2019+1.1%-8.4%+0.2%0.5×
Q1 FY2013 Aug 2019-2.3%+12.5%+19.0%14.3×
Q4 FY1919 Jul 2019-4.8%-8.0%+6.6%1.6×
Q3 FY191 Mar 2019-1.8%-1.8%-6.1%1.6×
Q2 FY1927 Nov 2018-3.8%+8.6%+7.1%0.4×
Q1 FY1924 Aug 2018-1.1%+8.1%-3.2%1.0×
Q4 FY1829 Jun 2018-4.4%+4.8%+3.6%5.8×
Q3 FY181 Mar 2018+1.7%-1.7%-3.3%1.0×
Q2 FY1822 Nov 2017-1.2%-6.3%-1.2%0.7×
Q1 FY1821 Aug 2017-4.9%-14.3%-23.9%0.0×
Q4 FY1717 Jun 2017-1.8%-10.5%+18.2%0.2×
Q3 FY171 Feb 2017+0.3%-4.0%-5.7%0.5×
Q2 FY1718 Nov 2016-1.6%+6.8%+63.4%0.3×
Q1 FY1731 Aug 2016-0.3%-1.9%+14.9%0.5×
Q4 FY162 Jun 2016-0.3%+11.3%+9.6%0.5×
Q3 FY1616 Feb 2016-3.2%+2.1%+2.6%0.6×
Q2 FY1614 Nov 2015-5.6%-9.8%+36.4%2.5×
Q1 FY1612 Aug 2015-2.1%-1.1%-12.0%0.9×
Q4 FY155 Jun 2015+0.5%+6.8%+7.3%1.6×
Q3 FY1519 Feb 2015+1.9%+15.7%+34.3%0.6×
Q2 FY1521 Nov 2014+7.0%+4.7%0.0%9.4×
Q1 FY1521 Aug 2014+2.2%-4.5%+6.7%1.2×
Q4 FY1427 May 2014+1.4%+1.4%+39.9%0.5×
Q3 FY145 Feb 2014-0.8%+6.1%+3.1%0.8×
Q2 FY146 Nov 2013-0.8%+3.3%+19.2%1.3×
Q1 FY1417 Aug 2013+6.0%+6.0%+6.0%0.5×
Q4 FY1331 May 2013-5.2%-6.7%-11.2%0.1×
Q3 FY1316 Feb 2013+0.7%+2.1%+3.6%1.6×
Q2 FY1312 Nov 20120.0%+0.6%+4.4%0.5×
Q1 FY137 Aug 2012-1.2%+2.5%-3.1%1.1×
Q4 FY1228 May 2012-2.9%-5.1%-5.7%1.0×
Q3 FY129 Feb 2012+2.2%+3.3%-2.7%1.0×
Q2 FY1210 Nov 2011-3.8%-15.2%-20.5%6.0×
Q1 FY124 Aug 2011-1.9%-5.1%-9.3%0.7×
Q4 FY1125 May 2011-3.5%-1.8%-7.5%2.4×
Q3 FY1116 Feb 2011-3.4%-5.6%-3.4%0.3×
Q2 FY1115 Nov 2010+0.5%-8.2%-20.4%2.8×
Q1 FY1111 Aug 2010-1.4%+2.5%-1.4%0.4×
Q4 FY1026 May 2010-1.4%-8.4%-20.4%1.2×
Q3 FY1028 Jan 2010-1.5%-3.4%-10.8%0.0×
Q2 FY1028 Oct 2009-1.4%+4.1%+10.4%0.7×
Q1 FY1027 Jul 2009+1.3%-2.2%+23.3%0.1×
Q4 FY095 May 2009+1.9%-1.5%-1.2%0.2×
Q3 FY0928 Jan 2009+0.4%+0.4%+5.0%0.2×
Q2 FY0929 Oct 2008+3.3%+39.8%+65.4%0.5×
Q1 FY091 Aug 2008+1.9%-6.3%-6.9%—
Average-0.5%+0.4%+4.2%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY21

CSV
Revenue YoY+26.2%
Profit YoY+12.6%
Interest cost YoY+200.1%
Revenue QoQ+25.3%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue+8.6%+6.2%+6.3%—+9.3%+5.2%
Profit-73.7%-66.8%-57.4%——-25.3%

Key data

CSV
Open114.85
Day range114.85 – 115.80
52-week range97.59 – 147.00
From 52w high-21.5%
RSI (14)53.6
ATR (14)3.46
Volume12.5K
Avg volume (20D)8.3K
Rel volume1.50×
Volatility (1Y)44.2%
Turnover₹14.4L
SMA 50 / 200114.56 / 116.41

Delivery percentage

Latest · 6 Oct 202687.4%
20-day avg79.8%
1-year avg71.8%
Percentile (own history)68th
Range8.8–100.0%
Sessions1,731

Over the last 20 sessions LOTUSEYE settled 79.8% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 71.8%, so recent sessions are running 8.1 points higher than usual. The latest session ranks higher than 68% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHospital
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price-0.21%+0.51%+5.57%-6.38%+12.55%-2.39%

Valuation

CSV
Market cap₹240 Cr
P/E (TTM)1607.0
EPS (TTM)0.07
Shares outstanding2.08Cr
Listed11 Jul 2008

Ownership

CSV
Promoter40.14%
Promoter Δ QoQ0.00 pp
Public59.86%
FII0.00%
DII0.02%
Pledged87.15%

Quarterly results · consolidated

CSV
Q2 FY21
Revenue (₹ Cr)7.2
YoY chg—
Net profit (₹ Cr)0.1
YoY chg—
Net margin1.1%
EPS0.04

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 40.14% · public 59.86%
30 Sept 2021: promoter 57.74%31 Dec 2021: promoter 57.74%31 Mar 2022: promoter 57.74%30 Jun 2022: promoter 57.74%30 Sept 2022: promoter 57.88%31 Dec 2022: promoter 58.14%31 Mar 2023: promoter 58.17%30 Jun 2023: promoter 58.43%30 Sept 2023: promoter 57.58%31 Dec 2023: promoter 56.58%31 Mar 2024: promoter 41.40%30 Jun 2024: promoter 40.24%30 Sept 2024: promoter 40.03%31 Dec 2024: promoter 40.14%31 Mar 2025: promoter 40.22%30 Jun 2025: promoter 40.39%30 Sept 2025: promoter 40.64%31 Dec 2025: promoter 39.67%31 Mar 2026: promoter 40.14%30 Jun 2026: promoter 40.14%
2021-092026-06
  • Promoter
  • Public and others
Promoter
40.14%
Public
59.86%
Promoter change
0.00 pp
Filed
16 Jul 2026
FII
0.00%
DII
0.02%
Promoter pledged
87.15%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY21
Revenue from operations7.2
Other income0.2
Total income7.4
Total expenses7.4
└ Finance costs0.0
└ Depreciation0.6
Profit before tax0.1
Tax expense(0.0)
Net profit0.1
EPS0.04
Net margin1.08%
PBT margin0.92%
Tax rate-16.77%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 12 Nov 2020.

1 quarter on file; a year-on-year comparison needs five.

LOTUSEYE at a glance

  • LOTUSEYE closed at ₹115.37 on 6 Oct 2026, -0.21% on the day, -2.4% over one year, 21.5% below its 52-week high of ₹147.
  • Delivery was 87.4% of traded quantity on 6 Oct 2026, the 68th percentile of its own 1,731 sessions with a reading (20-session average 79.8%, 1-year average 71.8%).
  • Market capitalisation is ₹240 crore at a trailing P/E of 1607.0 (trailing EPS ₹0.07).
  • Q2 FY21 results (consolidated, filed 12 Nov 2020): revenue ₹7 crore, net profit ₹0 crore; the price moved -0.7% on the first session after.
  • Promoters held 40.14% at 30 Jun 2026, unchanged on the previous filing, with 87.15% of promoter shares pledged.
  • Q2 FY27 results are expected between 12 Nov 2026 and 15 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHospital
ISININE947I01017
SeriesEQ
Listed11 Jul 2008
History from11 Jul 2008
Sessions4,480

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE